| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +2511.6% |
| Cost of Revenue | $327K | — |
| Gross Profit | $796K | +1751.2% |
| R&D Expense | $6.3M | +4.0% |
| SG&A Expense | $7.0M | +41.1% |
| Operating Income | -$12.5M | -14.0% |
| Pre-tax Income | -$11.2M | -27.6% |
| Income Tax | $2K | — |
| Net Income | -$11.2M | -26.7% |
| EPS (Basic) | -$0.32 | +20.0% |
| EPS (Diluted) | -$0.32 | +20.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -1.8% |
| Accounts Receivable | $139K | +223.3% |
| Inventory | $189K | — |
| Current Assets | $7.9M | +0.8% |
| Total Assets | $8.1M | -0.3% |
| Current Liabilities | $2.0M | +2.8% |
| Total Liabilities | $2.7M | -26.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | -20.3% |
| Capital Expenditures | $2K | -83.3% |
| Investing Cash Flow | -$2K | +83.3% |
| Financing Cash Flow | $10.8M | -28.3% |
| Free Cash Flow | -$11.0M | -20.1% |
| $5.4M |
| +21.1% |